Triple

T27348039
Position Surface form Disambiguated ID Type / Status
Subject Homo floresiensis E684280 entity
Predicate pathologyHypothesesConsidered P47125 FINISHED
Object Laron syndrome
Laron syndrome is a rare genetic disorder characterized by insensitivity to growth hormone, resulting in proportionate dwarfism and distinctive facial and metabolic features.
 E1767904 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Laron syndrome | Statement: [Homo floresiensis, pathologyHypothesesConsidered, Laron syndrome]
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Laron syndrome
Triple: [Homo floresiensis, pathologyHypothesesConsidered, Laron syndrome]
Generated description
Laron syndrome is a rare genetic disorder characterized by insensitivity to growth hormone, resulting in proportionate dwarfism and distinctive facial and metabolic features.
PD Predicate disambiguation gpt-5-mini-2025-08-07 
Target predicate: pathologyHypothesesConsidered
Context triple: [Homo floresiensis, pathologyHypothesesConsidered, Laron syndrome]
  • A. pathologyFeature
    Indicates that one entity is a pathological characteristic, sign, or abnormal finding associated with another entity in a medical or biological context.
  • B. targetsPathophysiology
    Indicates that an intervention, agent, or process is specifically directed at modifying or influencing a particular disease mechanism or pathological process.
  • C. differentialDiagnosisIncludes chosen
    Indicates that a differential diagnosis list for a case or condition contains a particular possible diagnosis as one of the considered alternatives.
  • D. hasEtiology
    Indicates that one entity is the cause, origin, or underlying reason for the occurrence or existence of another entity or condition.
  • E. asksToInvestigate
    Indicates that one entity requests another entity to carry out an investigation into something.
  • F. None of above.

Provenance (6 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ef1480a76481908684256ddd5bfda3 completed April 27, 2026, 7:47 a.m.
NER Named-entity recognition batch_69f62ba5a110819092fe773ade8fec2e completed May 2, 2026, 4:51 p.m.
NED1 Entity disambiguation (via context triple) batch_6a129ccb46588190b076fc5c8475879b completed May 24, 2026, 6:38 a.m.
NEDg Description generation batch_6a129dc563e081909b6e07e29aad6ddb completed May 24, 2026, 6:42 a.m.
NED2 Entity disambiguation (via description) batch_6a129e5f7e348190af4a279de8ef8caa completed May 24, 2026, 6:44 a.m.
PD Predicate disambiguation batch_69f623a91b9c8190b2e2fdbc55cb89b6 completed May 2, 2026, 4:17 p.m.
Created at: April 27, 2026, 11:46 a.m.